Detalles de la búsqueda
1.
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target.
Br J Haematol
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736325
2.
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.
Haematologica
; 108(12): 3278-3286, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021527
3.
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort.
Br J Haematol
; 197(5): 602-608, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362095
4.
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.
Pediatr Blood Cancer
; 69(9): e29753, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561075
5.
Monocyte-macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 193(6): 1157-1171, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713428
6.
Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia.
Acta Paediatr
; 110(2): 643-651, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33025591
7.
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(1): e28025, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571345
8.
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
Haematologica
; 104(3): 533-545, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262563
9.
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.
Haematologica
; 104(9): 1812-1821, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705097
10.
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Br J Haematol
; 182(5): 705-711, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29938780
11.
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Blood
; 127(17): 2101-12, 2016 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888258
12.
NUP214-ABL1 fusion in childhood T-ALL.
Pediatr Blood Cancer
; 69(9): e29643, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253360
13.
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study.
Blood
; 123(10): 1470-8, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24415536
14.
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?
Br J Haematol
; 164(3): 396-408, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24422724
15.
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.
Blood
; 130(19): 2146-2149, 2017 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939722
16.
Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative program.
Pediatr Blood Cancer
; 61(5): 827-32, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24376241
17.
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
J Clin Oncol
; 42(8): 915-926, 2024 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096462
18.
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
Haematologica
; 98(8): 1226-31, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23585525
19.
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.
Haematologica
; 98(11): 1702-10, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23716539
20.
Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
J Pediatr Hematol Oncol
; 35(5): 348-55, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23619106